FDA Drug Application (050775) for BIAXIN XL by ABBVIE

Back to FDA Applications sponsored by ABBVIE

Application Number050775
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage500MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameBIAXIN XL
Active IngredientCLARITHROMYCIN

Active IngredientCount
List of drugs with Active Ingredient CLARITHROMYCIN6


Back to FDA Applications sponsored by ABBVIE